Hydrobromides
TARGETMOL CHEMICALS INC TC-E 5003 200MG
Also available in 1 mL, 25 mg, 50 mg, 100 mg and bulk. Please contact Fisher for quotes. TC-E 5003 (NSC-30176) is a selective inhibitor of PRMT1 with IC50 of 1.5 uM. Purity 97.01%
Medchemexpress LLC L-2,4-diaminobutyric acid hydrobromide | 73143-97-2 | MFCD07368664 | 98.0% | 199.05 g/mol | C4H11BrN2O2 | 500 MG
L-2,4-diaminobutyric acid hydrobromide (L-DABA hydrobromide) is a research chemical described as a weak GABA transaminase inhibitor (IC50 > 500 μM) and reported to exhibit antitumor activity in vitro and in vivo. It is supplied as the hydrobromide salt, CAS 73143-97-2, with molecular weight 199.05 g/mol and reported purity 98.0%.
- High purity: 98.0%.
- Reported activity: weak GABA transaminase inhibitor (IC50 > 500 μM).
- Demonstrated antitumor activity in vitro and in vivo.
- Provided as hydrobromide salt for research use.
- Available in 500 mg pack size.
Medchemexpress LLC S-(2-aminoethyl) methanethiosulfonate hydrobromide | 16599-33-0 | 97.9% | 25 MG
MTSEA hydrobromide is a sulfhydryl-reactive reagent that selectively modifies free cysteine residues to introduce a positively charged side chain roughly the size of lysine. It is used in biochemical and electrophysiological studies to probe cysteine accessibility and to introduce charge at engineered cysteine sites.
- Sulfhydryl-reactive reagent for targeted cysteine modification.
- High supplied purity of 97.9%.
- Molecular weight 236.15 g/mol; formula C3H10BrNO2S2.
- Available in small solid packs suitable for research use.
- Store sealed at -20°C; in solution store at -80°C for long-term stability.
- CAS number 16599-33-0 for unambiguous identification.
eMolecules Oakwood Chemicals 1 8-Diazabicyclo[5 4 0]undec-7-ene 1kg 480122918 033415 0 000 6674-22-2 MFCD00006930 152 241 C9H16N2
Oakwood Chemicals 1 8-Diazabicyclo[5 4 0]undec-7-ene 1kg 480122918 033415 0 000 6674-22-2 MFCD00006930 152 241 C9H16N2
Medchemexpress LLC Burixafor hydrobromide | 1191450-19-7 | 98.0% | 769.01 | 200 MG
Burixafor (TG-0054) hydrobromide is a potent CXCR4 antagonist with a pIC50 of 7.4. It inhibits the binding of CXCL12 to CXCR4, antagonizes CXCL12-induced recruitment of Gαᵢ and β-arrestin2, and blocks the downstream Gαᵢ-mediated inhibitory effect on cAMP signal transduction. It mobilizes CD34+ hematopoietic stem/progenitor cells (HSPC) from the bone marrow to the peripheral blood and can be used for research on autologous hematopoietic stem cell transplantation (ASCT).
- Potent CXCR4 antagonist (pIC50 of 7.4)
- Inhibits CXCL12 binding to CXCR4
- Antagonizes CXCL12-induced recruitment of Gαᵢ and β-arrestin2
- Blocks downstream Gαᵢ-mediated inhibitory effect on cAMP signal transduction
- Mobilizes CD34+ hematopoietic stem/progenitor cells (HSPC) from bone marrow to peripheral blood
- Potential for research on autologous hematopoietic stem cell transplantation (ASCT)
Medchemexpress LLC Fenoterol hydrobromide | 1944-12-3 | 100.0% | 1 ML
Fenoterol hydrobromide (Th-1165a) is a sympathomimetic agent that acts as a selective and orally active β2-adrenoceptor agonist. It is an effective bronchodilator, making it suitable for research into bronchospasm associated with asthma, bronchitis, and other obstructive airway diseases.
- Selective and orally active β2-adrenoceptor agonist
- Functions as an effective bronchodilator
- Used in research for bronchospasm associated with asthma, bronchitis, and other obstructive airway diseases
Medchemexpress LLC Burixafor hydrobromide | 1191450-19-7 | 98.0% | 769.01 | 500 MG
Burixafor (TG-0054) hydrobromide is a potent CXCR4 antagonist with a pIC50 of 7.4. It inhibits the binding of CXCL12 to CXCR4, antagonizes CXCL12-induced recruitment of Gαᵢ and β-arrestin2, and blocks the downstream Gαᵢ-mediated inhibitory effect on cAMP signal transduction. Burixafor hydrobromide mobilizes CD34+ hematopoietic stem/progenitor cells (HSPC) from the bone marrow to the peripheral blood.
- Can be used for research on autologous hematopoietic stem cell transplantation (ASCT).
- Potent CXCR4 antagonist.
- Inhibits CXCL12 binding to CXCR4.
- Blocks Gαᵢ-mediated inhibitory effect on cAMP signal transduction.
- Mobilizes CD34+ hematopoietic stem/progenitor cells.
Medchemexpress LLC Oxidopamine (hydrobromide) | 636-00-0 | 99.4% | 500 MG
Oxidopamine (6-OHDA) hydrobromide is a potent neurotoxin that selectively destroys dopaminergic neurons by acting as an antagonist of the neurotransmitter dopamine. It is a valuable tool for research into various neurological conditions, including Parkinson's disease (PD), attention-deficit hyperactivity disorder (ADHD), and Lesch-Nyhan syndrome. The compound also promotes COX-2 activation, leading to PGE2 synthesis and pro-inflammatory cytokine IL-1β secretion.
- Selectively destroys dopaminergic neurons
- Antagonist of dopamine neurotransmitter
- Promotes COX-2 activation and PGE2 synthesis
- Induces pro-inflammatory cytokine IL-1β secretion
- Useful for Parkinson's disease research models
- Applicable in ADHD and Lesch-Nyhan syndrome studies
Medchemexpress LLC Arecoline hydrobromide | 300-08-3 | 99.95% | 500 MG
Arecoline hydrobromide is a naturally occurring, brain-penetrant, and orally active psychoactive alkaloid. It functions as a partial agonist for both nicotinic and muscarinic acetylcholine receptors, influencing various neurological processes. This compound has been noted for its ability to induce stimulation, alertness, anxiolysis, and anti-parasitic effects, though it can also cause oxidative stress.
- Naturally occurring psychoactive alkaloid
- Brain-penetrant and orally active
- Acts as a partial agonist of nicotinic and muscarinic acetylcholine receptors
- Can induce stimulation, alertness, anxiolysis, and anti-parasitic effects
- Induces reactive oxygen species and cell cycle arrest in HaCaT cells
- Alleviates anxiety and depression in CFA-induced mice
Medchemexpress LLC Halofuginone hydrobromide | 64924-67-0 | MFCD00946455 | 100.0% | 495.59 g·mol⁻¹ | C16H18Br2ClN3O3 | 10 MG
Halofuginone hydrobromide is a febrifugine derivative and a competitive prolyl-tRNA synthetase inhibitor used as a research standard for studies of collagen synthesis, TGF-β signaling, fibrosis, cancer biology, and anti-parasitic activity.
- Competitive prolyl-tRNA synthetase inhibitor with reported Ki ≈ 18.3 nM.
- Inhibits type-I collagen synthesis, useful for fibrosis and TGF-β studies.
- High reported purity (99.99%), suitable as a reference standard.
- Characterized molecular weight (495.59 g·mol⁻¹) and CAS number (64924-67-0).
- Available in small mg quantities for in vitro and pharmacological assays.